Skip to main content
Erschienen in: Digestive Diseases and Sciences 3/2022

29.03.2021 | Original Article

OPA Interacting Protein 5 Antisense RNA 1 Expedites Cell Migration and Invasion Through FOXM1/ Wnt/β-Catenin Pathway in Pancreatic Cancer

verfasst von: Chengjian Shi, Hang Zhang, Min Wang, Rui Tian, Xu Li, Yechen Feng, Feng Peng, Renyi Qin

Erschienen in: Digestive Diseases and Sciences | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Pancreatic cancer (PC) is a digestive tract malignancy with poor prognosis. Long noncoding RNA (lncRNA) OPA interacting protein 5 antisense RNA 1 (OIP5-AS1) was regarded to be correlated with human malignancy, working as tumor suppressor or promoter on the basis of tumor types. However, the function of OIP5-AS1 in PC remained unclear.

Aims

The study focused on the function and regulatory mechanism of OIP5-AS1 in PC.

Methods

OIP5-AS1 expression was assessed by the quantitative reverse transcription PCR (RT-qPCR) in tumor tissues and PC cell lines. 5-ethynyl-2′-deoxyuridine (EdU) incorporation and cell counting kit-8 (CCK-8) assays were applied to detect cell proliferation ability. Through wound healing and transwell assays, cell migration and invasion capacities were estimated. Flow cytometry analysis was performed to examine apoptosis capability of PC cells.

Results

OIP5-AS1 downregulating inhibited cell proliferation, migration, and invasion capacities, while promoting cell apoptosis rates. As a competing endogenous RNA (ceRNA), OIP5-AS1 competed with Forkhead Box M1 (FOXM1) for the binding sites on microRNA-320b (miR-320b). OIP5-AS1 was able to upregulate FOXM1 expression via silencing miR-320b. Furthermore, FOXM1 served as an activator of Wnt/β-catenin pathway and mediated the effect of OIP5-AS1 on Wnt/β-catenin pathway.

Conclusion

OIP5-AS1 expedites the proliferative, migrated, and invasive capability of PC cells, while repressing cell apoptosis through regulating miRNA-320b/FOXM1 axis and FOXM1/Wnt/β-catenin pathway in PC. OIP5-AS1 regulation on FOXM1/Wnt/β-catenin pathway may offer novel efficient markers for PC treatments.
Literatur
1.
Zurück zum Zitat Morrison AH, Byrne KT, Vonderheide RH. Immunotherapy and prevention of pancreatic cancer. Trends Cancer. 2018;4:418–428CrossRef Morrison AH, Byrne KT, Vonderheide RH. Immunotherapy and prevention of pancreatic cancer. Trends Cancer. 2018;4:418–428CrossRef
2.
Zurück zum Zitat Rhim AD, Mirek ET, Aiello NM et al. EMT and dissemination precede pancreatic tumor formation. Cell. 2012;148:349–361CrossRef Rhim AD, Mirek ET, Aiello NM et al. EMT and dissemination precede pancreatic tumor formation. Cell. 2012;148:349–361CrossRef
3.
Zurück zum Zitat Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet (London, England). 2011;378:607–620CrossRef Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet (London, England). 2011;378:607–620CrossRef
4.
Zurück zum Zitat Siegel RL, Miller KD, Jemal A. Cancer statistics 2017 CA. Cancer J Clin. 2017;67:7–30CrossRef Siegel RL, Miller KD, Jemal A. Cancer statistics 2017 CA. Cancer J Clin. 2017;67:7–30CrossRef
5.
Zurück zum Zitat Ren B, Cui M, Yang G et al. Tumor microenvironment participates in metastasis of pancreatic cancer. Mol Cancer. 2018;17:108CrossRef Ren B, Cui M, Yang G et al. Tumor microenvironment participates in metastasis of pancreatic cancer. Mol Cancer. 2018;17:108CrossRef
6.
Zurück zum Zitat Fogel EL, Shahda S, Sandrasegaran K et al. A multidisciplinary approach to pancreas cancer in 2016: a review. Am J Gastroenterol. 2017;112:537–554CrossRef Fogel EL, Shahda S, Sandrasegaran K et al. A multidisciplinary approach to pancreas cancer in 2016: a review. Am J Gastroenterol. 2017;112:537–554CrossRef
7.
Zurück zum Zitat Coveler AL, Herman JM, Simeone DM, Chiorean EG. Localized pancreatic cancer: multidisciplinary management. Am Soc Clin Oncol Edu Book Am Soc Clin Oncol Ann Meet. 2016;35:e217-226CrossRef Coveler AL, Herman JM, Simeone DM, Chiorean EG. Localized pancreatic cancer: multidisciplinary management. Am Soc Clin Oncol Edu Book Am Soc Clin Oncol Ann Meet. 2016;35:e217-226CrossRef
8.
Zurück zum Zitat Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155–159CrossRef Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155–159CrossRef
9.
Zurück zum Zitat Lin C, Yang L. Long Noncoding RNA in cancer: wiring signaling circuitry. Trends Cell Biol. 2018;28:287–301CrossRef Lin C, Yang L. Long Noncoding RNA in cancer: wiring signaling circuitry. Trends Cell Biol. 2018;28:287–301CrossRef
10.
Zurück zum Zitat Iyer MK, Niknafs YS, Malik R et al. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet. 2015;47:199–208CrossRef Iyer MK, Niknafs YS, Malik R et al. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet. 2015;47:199–208CrossRef
11.
Zurück zum Zitat Kim J, Abdelmohsen K, Yang X et al. LncRNA OIP5-AS1/cyrano sponges RNA-binding protein HuR. Nucl Acids Res. 2016;44:2378–2392CrossRef Kim J, Abdelmohsen K, Yang X et al. LncRNA OIP5-AS1/cyrano sponges RNA-binding protein HuR. Nucl Acids Res. 2016;44:2378–2392CrossRef
12.
Zurück zum Zitat Ulitsky I, Shkumatava A, Jan CH, Sive H, Bartel DP. Conserved function of lincRNAs in vertebrate embryonic development despite rapid sequence evolution. Cell. 2011;147:1537–1550CrossRef Ulitsky I, Shkumatava A, Jan CH, Sive H, Bartel DP. Conserved function of lincRNAs in vertebrate embryonic development despite rapid sequence evolution. Cell. 2011;147:1537–1550CrossRef
13.
Zurück zum Zitat Smith KN, Starmer J, Miller SC, Sethupathy P, Magnuson T. Long noncoding RNA moderates microRNA activity to maintain self-renewal in embryonic stem cells. Stem Cell Rep. 2017;9:108–121CrossRef Smith KN, Starmer J, Miller SC, Sethupathy P, Magnuson T. Long noncoding RNA moderates microRNA activity to maintain self-renewal in embryonic stem cells. Stem Cell Rep. 2017;9:108–121CrossRef
14.
Zurück zum Zitat Yang N, Chen J, Zhang H et al. LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma. Cell Death Dis. 2017;8:e2975CrossRef Yang N, Chen J, Zhang H et al. LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma. Cell Death Dis. 2017;8:e2975CrossRef
15.
Zurück zum Zitat Deng J, Deng H, Liu C, Liang Y, Wang S. Long non-coding RNA OIP5-AS1 functions as an oncogene in lung adenocarcinoma through targeting miR-448/Bcl-2. Biomed Pharmacother. 2018;98:102–110CrossRef Deng J, Deng H, Liu C, Liang Y, Wang S. Long non-coding RNA OIP5-AS1 functions as an oncogene in lung adenocarcinoma through targeting miR-448/Bcl-2. Biomed Pharmacother. 2018;98:102–110CrossRef
16.
Zurück zum Zitat Chang L, Guo R, Yuan Z, Shi H, Zhang D. LncRNA HOTAIR regulates CCND1 and CCND2 expression by sponging miR-206 in ovarian cancer. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol. 2018;49:1289–1303CrossRef Chang L, Guo R, Yuan Z, Shi H, Zhang D. LncRNA HOTAIR regulates CCND1 and CCND2 expression by sponging miR-206 in ovarian cancer. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol. 2018;49:1289–1303CrossRef
17.
Zurück zum Zitat Zhang X, Wu N, Wang J, Li Z. LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR-23a/APAF-1 axis. J Cell Mol Med. 2019. Zhang X, Wu N, Wang J, Li Z. LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR-23a/APAF-1 axis. J Cell Mol Med. 2019.
18.
Zurück zum Zitat Ma X, Qi S, Duan Z, et al. . Long non-coding RNA LOC554202 modulates chordoma cell proliferation and invasion by recruiting EZH2 and regulating miR-31 expression. Cell Prolif. 2017. Ma X, Qi S, Duan Z, et al. . Long non-coding RNA LOC554202 modulates chordoma cell proliferation and invasion by recruiting EZH2 and regulating miR-31 expression. Cell Prolif. 2017.
19.
Zurück zum Zitat Razek A, Elfar E, Abubacker S. Interobserver agreement of computed tomography reporting standards for chronic pancreatitis. Abdom Radiol N Y. 2019;44:2459–2465CrossRef Razek A, Elfar E, Abubacker S. Interobserver agreement of computed tomography reporting standards for chronic pancreatitis. Abdom Radiol N Y. 2019;44:2459–2465CrossRef
20.
Zurück zum Zitat Abdel Razek AAK, El-Serougy LG, Saleh GA, Abd El-Wahab R, Shabana W. Interobserver agreement of magnetic resonance imaging of liver imaging reporting and data system version 2018. J Comput Assist Tomogr. 2020;44:118–123CrossRef Abdel Razek AAK, El-Serougy LG, Saleh GA, Abd El-Wahab R, Shabana W. Interobserver agreement of magnetic resonance imaging of liver imaging reporting and data system version 2018. J Comput Assist Tomogr. 2020;44:118–123CrossRef
21.
Zurück zum Zitat Abdel Razek AAK, El-Serougy LG, Saleh GA, Shabana W, Abd El-Wahab R. Liver imaging reporting and data system version 2018: what radiologists need to know. J Comput Assist Tomogr. 2020;44:168–177CrossRef Abdel Razek AAK, El-Serougy LG, Saleh GA, Shabana W, Abd El-Wahab R. Liver imaging reporting and data system version 2018: what radiologists need to know. J Comput Assist Tomogr. 2020;44:168–177CrossRef
22.
Zurück zum Zitat Nandi D, Cheema PS, Jaiswal N, Nag A. FoxM1: Repurposing an oncogene as a biomarker. Semin Cancer Biol. 2018;52:74–84CrossRef Nandi D, Cheema PS, Jaiswal N, Nag A. FoxM1: Repurposing an oncogene as a biomarker. Semin Cancer Biol. 2018;52:74–84CrossRef
23.
Zurück zum Zitat Huang C, Du J, Xie K. FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis. Biochim et Biophys Acta. 2014;1845:104–116 Huang C, Du J, Xie K. FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis. Biochim et Biophys Acta. 2014;1845:104–116
24.
Zurück zum Zitat Cui J, Shi M, Xie D et al. FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression. Clin Cancer Res Offic J Am Assoc Cancer Res. 2014;20:2595–2606CrossRef Cui J, Shi M, Xie D et al. FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression. Clin Cancer Res Offic J Am Assoc Cancer Res. 2014;20:2595–2606CrossRef
25.
Zurück zum Zitat Huynh DL, Zhang JJ, Chandimali N et al. SALL4 suppresses reactive oxygen species in pancreatic ductal adenocarcinoma phenotype via FoxM1/Prx III axis. Biochem Biophys Res Commun. 2018;503:2248–2254CrossRef Huynh DL, Zhang JJ, Chandimali N et al. SALL4 suppresses reactive oxygen species in pancreatic ductal adenocarcinoma phenotype via FoxM1/Prx III axis. Biochem Biophys Res Commun. 2018;503:2248–2254CrossRef
26.
Zurück zum Zitat Li XY, Wu HY, Mao XF, Jiang LX, Wang YX. USP5 promotes tumorigenesis and progression of pancreatic cancer by stabilizing FoxM1 protein. Biochem Biophys Res Commun. 2017;492:48–54CrossRef Li XY, Wu HY, Mao XF, Jiang LX, Wang YX. USP5 promotes tumorigenesis and progression of pancreatic cancer by stabilizing FoxM1 protein. Biochem Biophys Res Commun. 2017;492:48–54CrossRef
27.
Zurück zum Zitat Chen Y, Li Y, Xue J et al. Wnt-induced deubiquitination FoxM1 ensures nucleus β-catenin transactivation. EMBO J. 2016;35:668–684CrossRef Chen Y, Li Y, Xue J et al. Wnt-induced deubiquitination FoxM1 ensures nucleus β-catenin transactivation. EMBO J. 2016;35:668–684CrossRef
28.
Zurück zum Zitat Pratheeshkumar P, Divya SP, Parvathareddy SK et al. FoxM1 and β-catenin predicts aggressiveness in Middle Eastern ovarian cancer and their co-targeting impairs the growth of ovarian cancer cells. Oncotarget. 2018;9:3590–3604CrossRef Pratheeshkumar P, Divya SP, Parvathareddy SK et al. FoxM1 and β-catenin predicts aggressiveness in Middle Eastern ovarian cancer and their co-targeting impairs the growth of ovarian cancer cells. Oncotarget. 2018;9:3590–3604CrossRef
29.
Zurück zum Zitat Kelleher FC, O’Sullivan H. FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways. Oncotarget. 2016;7:42792–42804CrossRef Kelleher FC, O’Sullivan H. FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways. Oncotarget. 2016;7:42792–42804CrossRef
30.
Zurück zum Zitat Batistela MS, Josviak ND, Sulzbach CD, de Souza RL. An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer’s and Parkinson’s Diseases. Int J Neurosci. 2017;127:547–558CrossRef Batistela MS, Josviak ND, Sulzbach CD, de Souza RL. An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer’s and Parkinson’s Diseases. Int J Neurosci. 2017;127:547–558CrossRef
31.
Zurück zum Zitat Hsu YC, Chang PJ, Ho C et al. Protective effects of miR-29a on diabetic glomerular dysfunction by modulation of DKK1/Wnt/beta-catenin signaling. Sci Rep. 2016;6:30575CrossRef Hsu YC, Chang PJ, Ho C et al. Protective effects of miR-29a on diabetic glomerular dysfunction by modulation of DKK1/Wnt/beta-catenin signaling. Sci Rep. 2016;6:30575CrossRef
32.
Zurück zum Zitat Keller A, Ludwig N, Fehlmann T, et al. Low miR-150–5p and miR-320b expression predicts reduced survival of COPD patients. Cells. 2019;8. Keller A, Ludwig N, Fehlmann T, et al. Low miR-150–5p and miR-320b expression predicts reduced survival of COPD patients. Cells. 2019;8.
33.
Zurück zum Zitat Lv QL, Du H, Liu YL et al. Low expression of microRNA-320b correlates with tumorigenesis and unfavorable prognosis in glioma. Oncol Rep. 2017;38:959–966CrossRef Lv QL, Du H, Liu YL et al. Low expression of microRNA-320b correlates with tumorigenesis and unfavorable prognosis in glioma. Oncol Rep. 2017;38:959–966CrossRef
Metadaten
Titel
OPA Interacting Protein 5 Antisense RNA 1 Expedites Cell Migration and Invasion Through FOXM1/ Wnt/β-Catenin Pathway in Pancreatic Cancer
verfasst von
Chengjian Shi
Hang Zhang
Min Wang
Rui Tian
Xu Li
Yechen Feng
Feng Peng
Renyi Qin
Publikationsdatum
29.03.2021
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 3/2022
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-06919-1

Weitere Artikel der Ausgabe 3/2022

Digestive Diseases and Sciences 3/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.